(Q83195713)
Statements
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma (English)
Mark J Ratain
James L Abbruzzese
Tim Eisen
Walter M Stadler
Keith T Flaherty
Stan B Kaye
Gary L Rosner
Martin Gore
Apurva A Desai
Amita Patnaik
Henry Q Xiong
Eric Rowinsky
Chenghua Xia
Peter J O'Dwyer